Fortress Biotech, Inc. Current Liabilities
Fortress Biotech, Inc. (FBIO) had Current Liabilities of $62.02 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Liabilities, Current $62.02M.
- 2026-03-31: Liabilities, Current $103.39M.
- 2025-12-31: Liabilities, Current $49.74M.
- 2025-09-30: Liabilities, Current $54.07M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $62.02M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $103.39M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $49.74M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $54.07M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $57.52M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $73.67M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $71.40M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $70.31M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $75.54M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $87.70M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $84.91M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $97.35M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $128.58M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $129.47M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $127.72M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $106.30M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $104.92M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $103.14M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $101.04M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $103.21M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $70.60M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $53.82M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $51.76M 10-K · filed 2022-03-28 | $47.96M 10-K · filed 2021-03-31 |
| 2020-09-30 | $37.28M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $56.97M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $51.73M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $45.62M 10-K/A · filed 2021-04-09 | |
| 2019-09-30 | $46.85M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $36.40M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $48.96M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $55.61M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $70.78M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $62.16M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $79.33M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $71.44M 10-K · filed 2019-03-18 | $67.43M 10-K · filed 2018-03-16 |
| 2017-09-30 | $68.43M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $53.47M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $52.80M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $56.56M 10-K · filed 2018-03-16 | |
| 2016-09-30 | $38.59M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $14.34M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $10.84M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $10.58M 10-K · filed 2017-03-16 | |
| 2015-09-30 | $8.45M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $5.00M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $5.93M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $4.08M 10-K · filed 2016-03-15 | |
| 2014-09-30 | $3.56M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $3.44M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $4.33M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $11.21M 10-K · filed 2015-03-16 | |
| 2013-09-30 | $9.64M 10-Q · filed 2013-11-01 | |
| 2013-06-30 | $8.95M 10-Q · filed 2013-08-05 | |
| 2013-03-31 | $6.17M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $5.13M 10-K · filed 2014-03-14 | |
| 2012-09-30 | $4.46M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $3.93M 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $3.84M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $3.49M 10-K · filed 2013-03-18 | |
| 2011-09-30 | $3.69M 10-Q · filed 2011-11-14 | |
| 2010-12-31 | $1.56M 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |